BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36939206)

  • 1. Knockdown of deoxythymidylate kinase suppresses progression and epithelial-mesenchymal-transition of lung adenocarcinoma via STAT3 signaling.
    Yu F; Chen Y; Qiu R; Lin N; Yin Y; Zhuo Y; Lin J; Lai F
    Physiol Genomics; 2023 May; 55(5):213-221. PubMed ID: 36939206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of DTYMK for estimating the immune microenvironment, diagnosis, prognosis effect in patients with lung adenocarcinoma.
    Chen X; Yuan Y; Zhou F; Huang X; Pu J; Niu X; Jiang X; Ding X
    Aging (Albany NY); 2022 Sep; 14(19):7866-7876. PubMed ID: 36170019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STEAP1 facilitates metastasis and epithelial-mesenchymal transition of lung adenocarcinoma via the JAK2/STAT3 signaling pathway.
    Huo SF; Shang WL; Yu M; Ren XP; Wen HX; Chai CY; Sun L; Hui K; Liu LH; Wei SH; Wang XX; Wang Y; Tian YX
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32515474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of DTYMK in pan-cancer and verification in lung adenocarcinoma.
    Zhang Y; Wang H; Liu Y; Yang J; Zuo X; Dong M; Zhang Z; Shi Y; Deng X; Lv Y
    Biosci Rep; 2022 Oct; 42(10):. PubMed ID: 36094557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PYCR1 knockdown inhibits the proliferation, migration, and invasion by affecting JAK/STAT signaling pathway in lung adenocarcinoma.
    Gao Y; Luo L; Xie Y; Zhao Y; Yao J; Liu X
    Mol Carcinog; 2020 May; 59(5):503-511. PubMed ID: 32133692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TMEM9 promotes lung adenocarcinoma progression via activating the MEK/ERK/STAT3 pathway to induce VEGF expression.
    Wang Z; Zhao P; Tian K; Qiao Z; Dong H; Li J; Guan Z; Su H; Song Y; Ma X
    Cell Death Dis; 2024 Apr; 15(4):295. PubMed ID: 38664392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UBE2T mediates SORBS3 ubiquitination to enhance IL-6/STAT3 signaling and promote lung adenocarcinoma progression.
    Pu J; Wang B; Zhang D; Wang K; Yang Z; Zhu P; Song Q
    J Biochem Mol Toxicol; 2024 Jun; 38(6):e23743. PubMed ID: 38816989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
    Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y
    Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chaperonin containing TCP1 subunit 3 (CCT3) promotes cisplatin resistance of lung adenocarcinoma cells through targeting the Janus kinase 2/signal transducers and activators of transcription 3 (JAK2/STAT3) pathway.
    Danni X; Jiangzheng Z; Huamao S; Yinglian P; Changcheng Y; Yanda L
    Bioengineered; 2021 Dec; 12(1):7335-7347. PubMed ID: 34612768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actin-like protein 8 promotes cell proliferation, colony-formation, proangiogenesis, migration and invasion in lung adenocarcinoma cells.
    Ma S; Wang X; Zhang Z; Liu D
    Thorac Cancer; 2020 Mar; 11(3):526-536. PubMed ID: 31962007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-15b enhances the proliferation and migration of lung adenocarcinoma by targeting BCL2.
    Wang J; Yao S; Diao Y; Geng Y; Bi Y; Liu G
    Thorac Cancer; 2020 Jun; 11(6):1396-1405. PubMed ID: 32220063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of RNF183 suppressed proliferation of lung adenocarcinoma cells
    Ye G; Luo H; Zhang T; Lan T; Ling B; Qi Z
    Cell Cycle; 2022 May; 21(9):948-960. PubMed ID: 35104174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Junctional adhesion molecule-like protein promotes tumor progression via the Wnt/β-catenin signaling pathway in lung adenocarcinoma.
    Wu Q; Li R; Wang QX; Zhang MY; Liu TT; Qu YQ
    J Transl Med; 2022 Jun; 20(1):260. PubMed ID: 35672776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of keratin 6C is associated with poor prognosis and accelerates cancer proliferation and migration by modulating epithelial-mesenchymal transition in lung adenocarcinoma.
    Hu HB; Yang XP; Zhou PX; Yang XA; Yin B
    Genes Genomics; 2020 Feb; 42(2):179-188. PubMed ID: 31768767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose-6-phosphate dehydrogenase promotes the proliferation and migration of lung adenocarcinoma cells via the STAT3 signaling pathway.
    Wu W; Yu F; Yu N; Zhu Y; Wu W; Gao P; Chen C
    J Mol Histol; 2022 Apr; 53(2):215-225. PubMed ID: 35028787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MTHFD2 promotes tumorigenesis and metastasis in lung adenocarcinoma by regulating AKT/GSK-3β/β-catenin signalling.
    Shi Y; Xu Y; Yao J; Yan C; Su H; Zhang X; Chen E; Ying K
    J Cell Mol Med; 2021 Jul; 25(14):7013-7027. PubMed ID: 34121323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LDH-A promotes malignant behavior via activation of epithelial-to-mesenchymal transition in lung adenocarcinoma.
    Hou XM; Yuan SQ; Zhao D; Liu XJ; Wu XA
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30509961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. lncRNA H19 promotes viability and epithelial-mesenchymal transition of lung adenocarcinoma cells by targeting miR-29b-3p and modifying STAT3.
    Liu L; Liu L; Lu S
    Int J Oncol; 2019 Mar; 54(3):929-941. PubMed ID: 30747209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-21-5p promotes lung adenocarcinoma cell proliferation, migration and invasion via targeting WWC2.
    Wang G; Zhou Y; Chen W; Yang Y; Ye J; Ou H; Wu H
    Cancer Biomark; 2020; 28(4):549-559. PubMed ID: 32623387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis.
    Jiang L; Wang R; Fang L; Ge X; Chen L; Zhou M; Zhou Y; Xiong W; Hu Y; Tang X; Li G; Li Z
    Theranostics; 2019; 9(9):2460-2474. PubMed ID: 31131047
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.